S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q3 2023

BVF Partners

Period: Q3 2023 Β· Filed: 2023-11-14
View on SEC EDGAR β†—
AUM
$3.71B
Total portfolio value
Positions
69
Reported securities
Top Holding
MLTX
33.4% $1.24B
QoQ Changes
+6 / -4
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.24B33.43%$57.58$18.95-67.1%
33.4%
IONSIONIS PHARMACEUTICALS INC$181.7M4.90%$43.43$81.80+88.3%
4.9%
AXSMAXSOME THERAPEUTICS INC$148.9M4.02%$66.85$244.31+265.5%
4.0%
IDYAIDEAYA BIOSCIENCES INC$142.6M3.84%$25.83$37.65+45.8%
3.8%
MIRMMIRUM PHARMACEUTICALS INC$138.1M3.72%$29.30$125.59+328.6%
3.7%
OLMAOLEMA PHARMACEUTICALS INC$112.8M3.04%$11.66$12.64+8.4%
3.0%
RVMDREVOLUTION MEDICINES INC$110.2M2.97%$26.17$189.24+623.1%
3.0%
RPTXREPARE THERAPEUTICS INC$100.2M2.70%β€”β€”
2.7%
PTGXPROTAGONIST THERAPEUTICS INC$95.8M2.58%$16.34$131.62+705.5%
2.6%
GHRSGH RESEARCH PLC$93.2M2.51%$10.31$27.01+162.0%
2.5%
GPCRSTRUCTURE THERAPEUTICS INC$88.2M2.38%$56.60$53.45-5.6%
2.4%
PNTPOINT BIOPHARMA GLOBAL INC$70.5M1.90%β€”β€”
1.9%
LKFTGALAPAGOS NV$66.2M1.78%$34.40$30.39-11.7%
1.8%
KYMRKYMERA THERAPEUTICS INC$65.9M1.78%$13.57$113.51+736.5%
1.8%
MRUSMERUS N V$64.9M1.75%β€”β€”
1.8%
XENEXENON PHARMACEUTICALS INC$62.4M1.68%$33.06$60.96+84.4%
1.7%
KURAKURA ONCOLOGY INC$61.4M1.66%$8.60$11.10+29.1%
1.7%
CNTACENTESSA PHARMACEUTICALS PLC$58.9M1.59%$5.62$40.50+620.6%
1.6%
XOMAXOMA CORP DEL$51.2M1.38%$14.02$43.00+206.7%
1.4%
FDMT4D MOLECULAR THERAPEUTICS IN$51.0M1.38%$11.81$13.00+10.1%
1.4%
ACRSACLARIS THERAPEUTICS INC$48.4M1.30%$6.49$5.56-14.3%
1.3%
JANXJANUX THERAPEUTICS INC$46.2M1.24%$9.50$15.54+63.6%
1.2%
TYRATYRA BIOSCIENCES INC$37.7M1.02%$13.09$30.62+133.9%
1.0%
ZYMEZYMEWORKS INC$37.2M1.00%$6.19$26.31+325.0%
1.0%
REPLREPLIMUNE GROUP INC$36.7M0.99%$15.79$11.58-26.7%
1.0%
ROIVROIVANT SCIENCES LTD$32.0M0.86%$10.52$35.13+233.9%
0.9%
CGEMCULLINAN ONCOLOGY INC$28.9M0.78%$8.38$17.63+110.4%
0.8%
ETNB89BIO INC$28.5M0.77%β€”β€”
0.8%
THRDTHIRD HARMONIC BIO INC$27.9M0.75%β€”β€”
0.8%
EPIXESSA PHARMA INC$27.0M0.73%β€”β€”
0.7%

Quarter-on-Quarter Activity

Q3 2023 vs. Q2 2023

New Positions (6)

TickerIssuerNotionalSince Filing
MIRMMIRUM PHARMACEUTICALS INC$138.1M+328.6%
ROIVROIVANT SCIENCES LTD$32.0M+233.9%
IMVTIMMUNOVANT INC$11.5M
MTEMMOLECULAR TEMPLATES INC$3.4M
UNCYUNICYCIVE THERAPEUTICS INC$2.9M
FBRXFORTE BIOSCIENCES INC$2.0M

Exited Positions (4)

TickerIssuerNotional
ARAVARAVIVE INC$6.0M
MTEMXXXXMOLECULAR TEMPLATES INC$2.4M
INFIQINFINITY PHARMACEUTICALS INC$1.3M
GLMDGALMED PHARMACEUTICALS LTD$0.3M

Increased (7)

TickerIssuerNotionalShares Ξ”Since Filing
ACRSACLARIS THERAPEUTICS INC$13.5M+110.2%-14.3%
MRUSMERUS N V$22.7M+71.8%
PTGXPROTAGONIST THERAPEUTICS INC$-8.5M+52.1%+705.5%
IONSIONIS PHARMACEUTICALS INC$64.9M+40.7%+88.3%
OLMAOLEMA PHARMACEUTICALS INC$44.1M+20.0%+8.4%
JANXJANUX THERAPEUTICS INC$-2.6M+11.5%+63.6%
KRONKRONOS BIO INC$-1.1M+3.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
BNOXBIONOMICS LIMITED$-0.1M-41.5%
RVMDREVOLUTION MEDICINES INC$-57.1M-36.4%+623.1%
ITOSITEOS THERAPEUTICS INC$-10.2M-30.4%
RLAYRELAY THERAPEUTICS INC$-19.3M-24.2%
DCTHDELCATH SYS INC$-2.9M-17.2%
LKFTGALAPAGOS NV$-21.9M-11.5%-11.7%
IDYAIDEAYA BIOSCIENCES INC$9.0M-7.0%+45.8%
CNTACENTESSA PHARMACEUTICALS PLC$0.6M-3.4%+620.6%
← Back to Hedge Funds